In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling.

Balkrishna A, Sinha S, Pandey A, Singh S, Joshi M, Singh R, Varshney A

Open source

DOI
10.1186/s10020-024-00888-7
Published
2024 Aug 11
Container
Molecular medicine (Cambridge, Mass.)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s10020-024-00888-7,
  title = {In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling.},
  author = {Balkrishna A and Sinha S and Pandey A and Singh S and Joshi M and Singh R and Varshney A},
  year = {2024},
  journal = {Molecular medicine (Cambridge, Mass.)},
  doi = {10.1186/s10020-024-00888-7},
  url = {https://doi.org/10.1186/s10020-024-00888-7}
}

RIS

TY  - JOUR
TI  - In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling.
AU  - Balkrishna A
AU  - Sinha S
AU  - Pandey A
AU  - Singh S
AU  - Joshi M
AU  - Singh R
AU  - Varshney A
PY  - 2024
JO  - Molecular medicine (Cambridge, Mass.)
DO  - 10.1186/s10020-024-00888-7
UR  - https://doi.org/10.1186/s10020-024-00888-7
ER  - 

APA

A, B., S, S., A, P., S, S., M, J., R, S., & A, V. (2024). In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-024-00888-7

Source records